VAW vs XBI
Vanguard Materials ETF vs SPDR S&P Biotech ETF
VAW$232.78
Vanguard Materials ETF
US materials sector stocks.
Expense: 0.09%Yield: 1.39%
XBI$156.41
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: 0.35%Yield: 0.35%
Quick take
- • VAW has the lower expense ratio at 0.09% vs 0.35% for XBI.
- • VAW pays a higher dividend yield (1.39%).
Side-by-side metrics
| Metric | VAW | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.09% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.39% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $4.38B | $10.92B |
YTD return | 13.71% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.88 | 1.01 |
P/E ratio | 23.49 | — |
Last price | $232.78 | $156.41 |
Inception | — | — |
Issuer | Vanguard | State Street |
VAW top holdings
Top holdings · VAW
| LIN | Linde PLC | 15.25% |
| NEM | Newmont Corp | 8.47% |
| FCX | Freeport-McMoRan Inc | 6.99% |
| SHW | Sherwin-Williams Co | 5.12% |
| ECL | Ecolab Inc | 4.83% |
| APD | Air Products and Chemicals Inc | 4.03% |
| CRH | CRH PLC | 3.84% |
| CTVA | Corteva Inc | 3.61% |
| NUE | Nucor Corp | 3.60% |
| VMC | Vulcan Materials Co | 2.20% |
Sector breakdown · VAW
Consumer Cyclical9.4%
Basic Materials89.4%
Consumer Defensive0.0%
Industrials0.6%
Energy0.0%
Healthcare0.5%
XBI top holdings
Top holdings · XBI
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%
About VAW
VAW (Vanguard Materials ETF) is US materials sector stocks. Managed by Vanguard, the fund carries $4.4B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.39%. Its largest holding is Linde PLC (LIN), which represents 15.2% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 9.4%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.